Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Rainer Freynhagen, Ralf Baron, Yoshiharu Kawaguchi, Rayaz A. Malik, Diane L. Martire, Bruce Parsons, Roberto D. Rey, Stephan A. Schug, Troels Staehelin Jensen, Thomas R. Tölle, Takahiro Ushida & Ed Whalen. (2021) Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration. Postgraduate Medicine 133:1, pages 1-9.
Read now
Read now
Alessandra Morano, Caterina Palleria, Rita Citraro, Valentina Nesci, Carmen De Caro, Anna Teresa Giallonardo, Giovambattista De Sarro, Emilio Russo & Carlo Di Bonaventura. (2019) Immediate and controlled-release pregabalin for the treatment of epilepsy. Expert Review of Neurotherapeutics 19:12, pages 1167-1177.
Read now
Read now
Evans Asamoah Adu, Christian Obirikorang, Emmanuel Acheampong, Aaron Siaw Kwakye, Foster Fokuoh, Yaa Obirikorang, Enoch Odame Anto, Emmanuella Nsenbah Batu, Brodrick Yeboah Amoah & Patience N. Ansong. (2019) Lipid accumulation product (LAP) index as a potential risk assessment for cardiovascular risk stratification among type II diabetes mellitus in a Ghanaian population: A cross-sectional study. Cogent Medicine 6:1.
Read now
Read now
Saad Javed, Uazman Alam & Rayaz A Malik. (2018) Mirogabalin and emerging therapies for diabetic neuropathy. Journal of Pain Research 11, pages 1559-1566.
Read now
Read now
Lesley M. Arnold, Ernest Choy, Daniel J. Clauw, Hiroshi Oka, Ed Whalen, David Semel, Lynne Pauer & Lloyd Knapp. (2018) An evidence-based review of pregabalin for the treatment of fibromyalgia. Current Medical Research and Opinion 34:8, pages 1397-1409.
Read now
Read now
Lesley M. Arnold, Bill H. McCarberg, Andrew G. Clair, Ed Whalen, Neal Thomas, Anamaria Jorga, Lynne Pauer, Richard Vissing & Peter W. Park. (2017) Dose–response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia. Postgraduate Medicine 129:8, pages 921-933.
Read now
Read now
Yvonne D’Arcy, Bill McCarberg, Bruce Parsons, Regina Behar, Andrew Thorpe & Andrea Alexander. (2017) Pregabalin for the treatment of neuropathic pain: a narrative review for primary care providers. Current Medical Research and Opinion 33:8, pages 1353-1359.
Read now
Read now
Bruce Parsons, Birol Emir & Andrew Clair. (2015) Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalin. Journal of Pain Research 8, pages 303-309.
Read now
Read now
Mark S. Juhn, Bruce Parsons, Roxanna Varvara & Alesia Sadosky. (2015) Pregabalin for painful diabetic peripheral neuropathy: strategies for dosing, monotherapy vs. combination therapy, treatment-refractory patients, and adverse events. Current Medical Research and Opinion 31:5, pages 1017-1026.
Read now
Read now
Sherifa Ahmed Hamed. (2015) Antiepileptic drugs influences on body weight in people with epilepsy. Expert Review of Clinical Pharmacology 8:1, pages 103-114.
Read now
Read now
Joseph Chukwu, Norman Delanty, David Webb & Gianpiero L Cavalleri. (2014) Weight change, genetics and antiepileptic drugs. Expert Review of Clinical Pharmacology 7:1, pages 43-51.
Read now
Read now
Charlotte Both, Georg Kojda & Christian Lange-Asschenfeldt. (2014) Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin. Expert Review of Neurotherapeutics 14:1, pages 29-38.
Read now
Read now
Stuart Montgomery, Birol Emir, Hannah Haswell & Rita Prieto. (2013) Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability. Current Medical Research and Opinion 29:10, pages 1223-1230.
Read now
Read now
H. Parmentier, J. García-Campayo & R. Prieto. (2013) Comprehensive review of generalized anxiety disorder in primary care in Europe. Current Medical Research and Opinion 29:4, pages 355-367.
Read now
Read now
Articles from other publishers (16)
Sarah Sauchelli, Julia Bradley, Jennifer Cox, Clare England & Rachel Perry. (2020) Weight maintenance interventions for people with type 2 diabetes mellitus: a systematic review protocol. Systematic Reviews 9:1.
Crossref
Crossref
David S. Baldwin. 2020. Generalized Anxiety Disorder and Worrying. Generalized Anxiety Disorder and Worrying
297
318
.
Mahindra Chincholkar. (2020) Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice. British Journal of Pain 14:2, pages 104-114.
Crossref
Crossref
I-Ferne Tan & Andrew W. Horne. 2020. Obesity and Gynecology. Obesity and Gynecology
281
291
.
E. V. Tsallagova, V. O. Generalov & T. R. Sadykov. (2018) Hyperandrogenism as a side effect of anticonvulsants. Epilepsia and paroxyzmal conditions 10:2, pages 43-50.
Crossref
Crossref
Ole Schjerning, Per Damkier, Signe Engelhardt Lykkegaard, Klaus Damgaard Jakobsen & Jimmi Nielsen. (2018) Pregabalin for anxiety in patients with schizophrenia — A randomized, double-blind placebo-controlled study. Schizophrenia Research 195, pages 260-266.
Crossref
Crossref
David S Baldwin, Johan A den Boer, Gavin Lyndon, Birol Emir, Edward Schweizer & Hannah Haswell. (2015) Efficacy and safety of pregabalin in generalised anxiety disorder: A critical review of the literature. Journal of Psychopharmacology 29:10, pages 1047-1060.
Crossref
Crossref
Luc Van Gaal & André Scheen. (2015) Weight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment. Diabetes Care 38:6, pages 1161-1172.
Crossref
Crossref
Rainer Freynhagen, Michael Serpell, Birol Emir, Ed Whalen, Bruce Parsons, Andrew Clair & Mark Latymer. (2013) A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain. Pain Practice 15:1, pages 47-57.
Crossref
Crossref
Samer Narouze & Dmitri Souzdalnitski. (2015) Obesity and Chronic Pain. Regional Anesthesia and Pain Medicine 40:2, pages 91-111.
Crossref
Crossref
James E. Frampton. (2014) Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder. CNS Drugs 28:9, pages 835-854.
Crossref
Crossref
Pavel Klein & Jaromir Janousek. 2014. Women with Epilepsy. Women with Epilepsy
65
79
.
Cory Toth. (2013) Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Therapeutic Advances in Drug Safety 5:1, pages 38-56.
Crossref
Crossref
Kevin L Dalal, Elizabeth R Felix & Diana D Cardenas. (2013) Pregabalin for the management of neuropathic pain in spinal cord injury. Pain Management 3:5, pages 359-367.
Crossref
Crossref
Stephen M. Stahl, Frank Porreca, Charles P. Taylor, Raymond Cheung, Andrew J. Thorpe & Andrew Clair. (2013) The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?. Trends in Pharmacological Sciences 34:6, pages 332-339.
Crossref
Crossref
Heather K. Vincent, Meredith C.B. Adams, Kevin R. Vincent & Robert W. Hurley. (2013) Musculoskeletal Pain, Fear Avoidance Behaviors, and Functional Decline in Obesity. Regional Anesthesia and Pain Medicine 38:6, pages 481-491.
Crossref
Crossref